News thumbnail
Top / Fri, 20 Nov 2026 Cure Today

5 Pancreatic Cancer Numbers Patients and Families Should Know

A "five-year relative survival rate" compares people with a cancer to people of the same age in the general population. Pancreatic Cancer Is the Third Leading Cause of Cancer DeathAn estimated 52,740 people will die of pancreatic cancer in 2026, making it the third leading cause of cancer death in the U.S. among both men and women, behind lung and colorectal cancers. In 2026, the FDA approved Rasonque, a first-in-class targeted therapy for metastatic pancreatic cancer , and CURE has shared how one patient moved from chemotherapy to Rasonque . Many experts encourage people with pancreatic cancer to ask about trials early, at diagnosis and again whenever treatment changes, rather than waiting until other options run out. References"Cancer Statistics, 2026."

A "five-year relative survival rate" compares people with a cancer to people of the same age in the general population. It is an average across everyone diagnosed, at every stage and every level of health. It is not a prediction for you, and it does not mean people live only five years. It counts how many people are still alive five years after diagnosis, and many of them live longer.

3. Stage at Diagnosis Changes the Outlook

Only 17% of people are diagnosed while the cancer is still localized, meaning it has not spread beyond the pancreas. For that group, five-year survival is 44%, more than three times the overall rate.

That is one reason doctors focus so closely on whether a tumor is resectable, meaning it can be removed with surgery such as a Whipple procedure. If you are not sure what stage your cancer is, or whether surgery is possible now or after chemotherapy, ask your oncologist to walk you through it.

4. Pancreatic Cancer Is the Third Leading Cause of Cancer Death

An estimated 52,740 people will die of pancreatic cancer in 2026, making it the third leading cause of cancer death in the U.S. among both men and women, behind lung and colorectal cancers. Advocacy groups note it is the only major cancer with a five-year survival rate below 20%.

This number explains why researchers and advocates are pushing so hard for better treatments. For you, it is a reason to ask about palliative care, which is specialized care for symptoms like pain, weight loss and fatigue. Palliative care can start at diagnosis, alongside treatment meant to control the cancer. It is not the same as hospice.

5. Today's Statistics Lag Behind Today's Treatments

Survival statistics are built from people who were diagnosed years ago, so they cannot reflect treatments that have become available since. In 2026, the FDA approved Rasonque, a first-in-class targeted therapy for metastatic pancreatic cancer , and CURE has shared how one patient moved from chemotherapy to Rasonque . Other research, such as a study of a device called Optune Pax that delayed pain in locally advanced pancreatic cancer , is focused on helping people feel better while they live with the disease.

Clinical trials are another path. Many experts encourage people with pancreatic cancer to ask about trials early, at diagnosis and again whenever treatment changes, rather than waiting until other options run out.

Statistics describe groups, and people are individuals. Survivors such as Dan, who shared his path from stage 4 to survivor , are a reminder that every number has people on both sides of it. Your own outlook depends on your stage, your tumor's features, your overall health and how you respond to treatment, and your care team is the best source for what the numbers mean for you.

References

"Cancer Statistics, 2026." American Cancer Society. CA: A Cancer Journal for Clinicians. January 2026. "Cancer Facts & Figures 2026." American Cancer Society. January 2026.

© All Rights Reserved.